Chronic obstructive pulmonary disease
Conditions
Interventions
Conrol group:Pseudo acupoint sticking group
acupoint sticking group:Pseudo acupoint sticking group
Sponsors
Affiliated Hospital of Beijing Medical University
Eligibility
Sex/Gender
Male
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with chronic obstructive pulmonary disease who meet the criteria of the Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2013) and are in stable stage. (2) Conforming to the criteria of TCM diagnosis and syndrome differentiation of the disease. (3) Age 40-80, Obtaining Informed Consent (Informed consent process: follow the principle of full disclosure, full understanding, and independent choice. In this clinical study, the researcher of this study selects the subjects who meet this study according to the diagnostic criteria, inclusive criteria, etc., and introduces the content of this study to the subjects in detail, obtains their informed consent, and guides them to sign the informed consent form, so as to ensure the interests of both doctors and patients. In this process, various questions raised by the patients should be answered in detail.). (4) Good compliance, with treatment, can accept telephone follow-up, did not participate in other clinical researchers. (5) See the patient in the Affiliated Hospital of North Sichuan Medical College.
Exclusion criteria
Exclusion criteria: (1) Patients with chronic obstructive pulmonary disease who do not meet the criteria of the 2013 Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease or are not in a stable period. (2) Women under 40 years old or over 80 years old, pregnant and lactating. (3) Allergic constitution or allergy to multiple drugs. (4) There are any cases that are not suitable for inclusion in the study (including: patients with very severe COPD, patients with serious primary diseases such as cardiovascular disease, liver and kidney disease and hematopoietic system, psychiatric patients, pregnant and lactating women, and other serious diseases that seriously affect the quality of life).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function test; | — |
Countries
China
Contacts
Public ContactZHANG boda
Outcome results
None listed